Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP)

T. Welte, T. W. L. Scheeren, A. Rodriguez, A. Demange, M. Engelhardt (Hannover, Germany; Groningen, Netherlands; Tarragona, Spain; Allschwil, Basel, Switzerland)

Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Session: Respiratory infections: inflammation and treatment
Session type: Oral Presentation
Number: 4643
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Welte, T. W. L. Scheeren, A. Rodriguez, A. Demange, M. Engelhardt (Hannover, Germany; Groningen, Netherlands; Tarragona, Spain; Allschwil, Basel, Switzerland). Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP). Eur Respir J 2014; 44: Suppl. 58, 4643

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severe community-acquired pneumonia in alcoholic patients hospitalized in intensive care unit
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Microbiological vs non-microbiological confirmed nnventilator ICU-acquired pneumonia
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Effect of adherence to guidelines on mortality, length of stay and critical care admission in community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Prognostic factors of the patients admitted to intensive care unit with nursing and healthcare-associated pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

Antibiotic prescription patterns for treating respiratory infections across intensive care unit (ICUs) in India
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Nosocomial pneumonia in intensive care unit
Source: Eur Respir J 2002; 20: Suppl. 38, 475s
Year: 2002

Immunoglobulin levels and severity of community-acquired pneumonia (CAP)
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014


Effect of giving antibiotics within 4 hours to patients with community-acquired pneumonia on mortality, length of stay and critical care admission
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Nursing and healthcare-associated pneumonia requiring hospital admission: Microbiology and clinical outcomes
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Hypercapnia as a marker of ICU admission and prolonged hospitalization in patients with community-acquired pneumonia
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015



The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units- A prospective cohort observational study
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016

Ventilator associated pneumonia in a respiratory intensive care unit: What has changed during three years period?
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Etiological features of nosocomial pneumonia in neurosurgical intensive care unit
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013

Profile of patients with community acquired pneumonia (CAP) admitted to a respiratory intermediate care unit (RICU)
Source: Eur Respir J 2006; 28: Suppl. 50, 132s
Year: 2006

Epidemiology of antibiotics prescribtion for treatment of hospital-acquired pnemonia (HAP) in ICU
Source: Eur Respir J 2004; 24: Suppl. 48, 547s
Year: 2004

Assessment of severity of intensive care unit-acquired pneumonia and association with aetiology
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
Source: Eur Respir J 2006; 27: 1210-1216
Year: 2006



A study of antibiogram assay, risk factors and etiology of ventilator associated pneumonia (VAP) in a tertiary care hospital of Pakistan
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013

Epidemiology and outcome of hospital-acquired and ventilator-associated pneumonia at the Philippine General Hospital central intensive care unit
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007


Impact of candida spp. colonization of respiratory tract in patients with intensive care unit-acquired pneumonia
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013